A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Clinical trial NCT02875340 · COMPLETED

Trial details

NCT number: NCT02875340
Sponsor: ValiSeek Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Adenocarcinoma

Start date: 2016-10-01
Primary completion: 2017-09-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.